Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Phibro Animal Health stock

PAHC
US71742Q1067
A1WZ6P

Price

22.08
Today +/-
-0.40
Today %
-1.97 %
P

Phibro Animal Health stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Phibro Animal Health stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Phibro Animal Health stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Phibro Animal Health stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Phibro Animal Health's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Phibro Animal Health Stock Price History

DatePhibro Animal Health Price
10/1/202422.08 undefined
9/30/202422.52 undefined
9/27/202422.07 undefined
9/26/202422.10 undefined
9/25/202422.07 undefined
9/24/202422.04 undefined
9/23/202421.99 undefined
9/20/202422.28 undefined
9/19/202422.41 undefined
9/18/202422.15 undefined
9/17/202422.36 undefined
9/16/202421.53 undefined
9/13/202421.99 undefined
9/12/202421.21 undefined
9/11/202420.45 undefined
9/10/202420.88 undefined
9/9/202420.53 undefined
9/6/202419.46 undefined
9/5/202419.42 undefined
9/4/202419.65 undefined
9/3/202419.87 undefined

Phibro Animal Health Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Phibro Animal Health, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Phibro Animal Health from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Phibro Animal Health’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Phibro Animal Health. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Phibro Animal Health’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Phibro Animal Health’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Phibro Animal Health’s growth potential.

Phibro Animal Health Revenue, EBIT and net profit per share

DatePhibro Animal Health RevenuePhibro Animal Health EBITPhibro Animal Health Net Income
2029e1.18 B undefined120.36 M undefined0 undefined
2028e1.16 B undefined117.3 M undefined0 undefined
2027e1.57 B undefined114.24 M undefined84.69 M undefined
2026e1.32 B undefined106.59 M undefined69.19 M undefined
2025e1.18 B undefined99.11 M undefined64.44 M undefined
20241.02 B undefined74.58 M undefined2.42 M undefined
2023977.9 M undefined71.8 M undefined32.6 M undefined
2022942.3 M undefined79 M undefined49.2 M undefined
2021833.4 M undefined74.9 M undefined54.4 M undefined
2020800.4 M undefined67.3 M undefined33.6 M undefined
2019828 M undefined81.7 M undefined54.7 M undefined
2018820 M undefined98.9 M undefined64.9 M undefined
2017764.3 M undefined97.9 M undefined64.6 M undefined
2016751.5 M undefined85.7 M undefined82.7 M undefined
2015748.6 M undefined87.7 M undefined60.3 M undefined
2014691.9 M undefined63.8 M undefined-3.1 M undefined
2013653.2 M undefined56.7 M undefined24.9 M undefined
2012654.1 M undefined49.3 M undefined7 M undefined
2011618.3 M undefined41.2 M undefined-12.9 M undefined
2010594.2 M undefined52.8 M undefined42.1 M undefined
2009537.1 M undefined45 M undefined-8.3 M undefined
2008511.4 M undefined29.3 M undefined2.2 M undefined
2007453 M undefined35.1 M undefined-6.7 M undefined
2006398.4 M undefined23 M undefined-13.1 M undefined
2005364.4 M undefined4.4 M undefined-18.8 M undefined

Phibro Animal Health Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e2028e2029e
0.320.320.330.340.350.360.40.450.510.540.590.620.650.650.690.750.750.760.820.830.80.830.940.981.021.181.321.571.161.18
--1.242.822.745.042.829.3413.8212.805.0910.614.045.83-0.155.828.250.401.737.330.98-3.384.1313.093.724.0915.9311.7918.82-26.252.16
22.6021.6324.7026.4125.1419.5122.8624.5023.6824.0225.9323.6225.0827.4129.5231.1531.8232.4632.4431.8832.0032.5330.2530.5030.78-----
7369818989719111112112915414616417920423323924826626425627128529831300000
15510252542335294552414956638785979881677479717499106114117120
4.641.573.057.427.061.105.787.735.688.388.756.637.498.589.1211.6311.3212.7011.959.788.388.888.397.277.288.408.047.2810.1310.17
10-14-59-2921-18-13-62-842-12724-3608264645433544932264698400
--240.00321.43-50.85-172.41-185.71-27.78-53.85-133.33-500.00-625.00-128.57-158.33242.86-112.50-2,100.0036.67-21.95--15.63-38.8963.64-9.26-34.69-93.753,100.007.8121.74--
------------------------------
------------------------------
0000060600038.838.838.838.838.832.239.8404040.440.540.540.540.540.540.5200000
------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Phibro Animal Health Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Phibro Animal Health is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
200020012002200320042005200620072012201320142015201620172018201920202021202220232024
                                         
2.414.86.411.25.6138.71253.927.411.829.233.656.179.281.691.393.291.281.3114.61
79.477.95852.757.252.854.47299.199.1113.9111.1123.8125.8135.7159126.5146.9166.5163.5169.45
8.54.83.13.52.83.64.64.10000000000000
50.483.885.487.878.696.696.889.4120.1140143.2149.8167.7161.2178.2198.3196.7216.3259.2277.6265.91
9.117.432.119.210.512.812.21428.729.830.423.617.720.522.427.237.342.549.363.451.02
149.8198.7185174.4154.7178.8176.7191.5301.8296.3299.3313.7342.8363.6415.5466.1451.8498.9566.2585.8601
76.2102.365.763.955.45051.353.6101.7104.4109.2104.4127.3127.4130.1140.2171187.7203.2231.3240.9
000000005.45.410.29.59.49.39.29.61010.110.311.111.49
000000000005550000000
6.35.69.68.711.710.28.87.41535.229.837.360.154.65247.57162.363.95545.03
000000001.712.612.612.621.12427.327.352.752.753.253.354.56
26.223.336.227.419.714.111.519.415.220.211.210.842.139.537.635.827.629.734.93529.21
108.7131.2111.510086.874.371.680.4139177.8173179.6265259.8256.2260.4332.3342.5365.5385.7381.19
258.5329.9296.5274.4241.5253.1248.3271.9440.8474.1472.3493.3607.8623.4671.7726.5784.1841.4931.7971.5982.18
                                         
50050050050050050050000000000000004
0.90.90.70.90.927.30.90.842.742.9132.5118.2118.3123.8129.9133.3135.5135.8135.8135.8136.28
32.89.7-49.7-79.5-58-74.4-89.9-96.6-116-94.1-97.2-373482.8131.6168.9183.1218247.7260.9243.89
-2.6-7.7-13.9-6.5-7.31.54.87.8-15-17.8-20.1-51.6-61.8-55.4-76.5-86.2-130.4-115.3-121.1-114.2-123.53
001.10.100.1000000000000000
31.63.4-61.3-84.5-63.9-45-83.7-88-88.3-6915.229.690.5151.2185216188.2238.5262.4282.5256.64
32.651.338.255.446.836.341.64667.957.959.663.160.256.959.573.266.168.495.673.985.57
22.132.326.131.539.453.849.542.83536.723.826.425.43334.736.73848.347.541.252.95
23.112.114.80.8008.517.620.726.11920.319.736.531.834.438.132.838.635.84
10.832.749.339.611.98.28.500000000000000
2.35.48.924.11.41.61.30.55.40.132.82.96.312.612.518.89.41522.329.8
69.8124.8134.6165.4100.399.9100.997.8125.9115.4112.5111.3108.8115.9143.3154.2157.3164.2190.9176204.15
139.7139.5136.6102.3158176.5209.8240.1344.8365.5286.4286.7347.3306.9299.8313.6368.3382.7417.9452.5458.29
0000000013.917.614.319.18.28.90011.76.69.312.114.22
17.262.486.591.34721.521.32244.644.64446.653.140.643.742.858.749.351.248.248.89
156.9201.9223.1193.6205198231.1262.1403.3427.7344.7352.4408.6356.4343.5356.4438.7438.6478.4512.8521.4
226.7326.7357.7359305.3297.9332359.9529.2543.1457.2463.7517.4472.3486.8510.6596602.8669.3688.8725.54
258.3330.1296.4274.5241.4252.9248.3271.9440.9474.1472.4493.3607.9623.5671.8726.6784.2841.3931.7971.3982.18
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Phibro Animal Health provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Phibro Animal Health's financial health and stability.

Assets

Phibro Animal Health's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Phibro Animal Health must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Phibro Animal Health after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Phibro Animal Health's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
200020012002200320042005200620072011201220132014201520162017201820192020202120222023
10-14-51-1712-22-13-6-12624-3608264645433544932
111012101018131016171921212326262732313234
1-51160-1010-2-1214-220608-20-2
-1527-3160-1-3-19-85-33-28-16-460-33-35-13-29-44-41
-15-32718-200490437007631-4-4-9
131617161721222030343345121414111211101114
1022415537712101614151620191720
-713-4342-60-4-43110683798704759483113
-22-6-8-8-6-7-15-10-21-14-19-19-20-36-20-18-29-34-29-37-51
-4-40-17-390-5-11-19-17-38-19-34-82-21-84-14-120-18-22-74
18-33-841579-12-2-180-14-46-1-6615-861014-22
000000000000000000000
11015-26464402968-814-80-162-39-1136054042
045000-2600000114145510000
113913-26-171401910-8104-1550-53-11-440-171626
0-4-10-64-40-8-580-3-400-3000-2-43
00000000000-25-15-15-15-16-18-19-19-19-19
012-84-58-43-145-26-1517422-2628-211324-32
-30.516.53-13.2726.15-3.27-13.65-14.28-15.35-26.3217.06-18.51-20.5648.640.8777.5151.4617.2825.318.99-5.39-38.48
000000000000000000000

Phibro Animal Health stock margins

The Phibro Animal Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Phibro Animal Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Phibro Animal Health.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Phibro Animal Health's sales revenue. A higher gross margin percentage indicates that the Phibro Animal Health retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Phibro Animal Health's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Phibro Animal Health's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Phibro Animal Health's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Phibro Animal Health. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Phibro Animal Health's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Phibro Animal Health Margin History

Phibro Animal Health Gross marginPhibro Animal Health Profit marginPhibro Animal Health EBIT marginPhibro Animal Health Profit margin
2029e30.82 %10.19 %0 %
2028e30.82 %10.16 %0 %
2027e30.82 %7.3 %5.41 %
2026e30.82 %8.09 %5.25 %
2025e30.82 %8.41 %5.47 %
202430.82 %7.33 %0.24 %
202330.49 %7.34 %3.33 %
202230.29 %8.38 %5.22 %
202132.57 %8.99 %6.53 %
202032.1 %8.41 %4.2 %
201931.96 %9.87 %6.61 %
201832.55 %12.06 %7.91 %
201732.47 %12.81 %8.45 %
201631.8 %11.4 %11 %
201531.16 %11.72 %8.06 %
201429.54 %9.22 %-0.45 %
201327.4 %8.68 %3.81 %
201225.09 %7.54 %1.07 %
201123.73 %6.66 %-2.09 %
201026.04 %8.89 %7.09 %
200924.15 %8.38 %-1.55 %
200823.82 %5.73 %0.43 %
200724.55 %7.75 %-1.48 %
200622.87 %5.77 %-3.29 %
200519.57 %1.21 %-5.16 %

Phibro Animal Health Stock Sales Revenue, EBIT, Earnings per Share

The Phibro Animal Health earnings per share therefore indicates how much revenue Phibro Animal Health has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Phibro Animal Health earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Phibro Animal Health's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Phibro Animal Health’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Phibro Animal Health's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Phibro Animal Health Revenue, EBIT and net profit per share

DatePhibro Animal Health Sales per SharePhibro Animal Health EBIT per sharePhibro Animal Health Earnings per Share
2029e29.16 undefined0 undefined0 undefined
2028e28.52 undefined0 undefined0 undefined
2027e38.67 undefined0 undefined2.09 undefined
2026e32.54 undefined0 undefined1.71 undefined
2025e29.11 undefined0 undefined1.59 undefined
202425.11 undefined1.84 undefined0.06 undefined
202324.15 undefined1.77 undefined0.8 undefined
202223.27 undefined1.95 undefined1.21 undefined
202120.58 undefined1.85 undefined1.34 undefined
202019.76 undefined1.66 undefined0.83 undefined
201920.44 undefined2.02 undefined1.35 undefined
201820.3 undefined2.45 undefined1.61 undefined
201719.11 undefined2.45 undefined1.62 undefined
201618.79 undefined2.14 undefined2.07 undefined
201518.81 undefined2.2 undefined1.52 undefined
201421.49 undefined1.98 undefined-0.1 undefined
201316.84 undefined1.46 undefined0.64 undefined
201216.86 undefined1.27 undefined0.18 undefined
201115.94 undefined1.06 undefined-0.33 undefined
201015.31 undefined1.36 undefined1.09 undefined
200913.84 undefined1.16 undefined-0.21 undefined
20080 undefined0 undefined0 undefined
20070 undefined0 undefined0 undefined
20066.64 undefined0.38 undefined-0.22 undefined
20056.07 undefined0.07 undefined-0.31 undefined

Phibro Animal Health business model

Phibro Animal Health Corp is a globally leading company specializing in the research, development, production, and marketing of animal health products. The company was founded in 1947 and is headquartered in Teaneck, New Jersey, USA. The company originally produced additives and aids for the food industry but recognized the potential of the animal health market in the 1950s and shifted its focus to developing and marketing animal health products. In the 1970s, the company introduced the first antibiotic for agricultural animals. Phibro Animal Health Corp's business model is to manufacture innovative animal health products and sell them to livestock owners, veterinarians, agricultural farms, and other customers worldwide. The company aims to improve the quality of life and production conditions of livestock by focusing on the prevention and treatment of diseases and infections. Phibro Animal Health Corp has two main business segments: Animal Health and Performance. In the Animal Health segment, the company offers products for the prevention and treatment of diseases in livestock such as pigs, poultry, cattle, and fish. These products include vaccines, antibiotics, other medications, as well as feed additives and disinfectants. In the Performance segment, the company offers feed additives and special minerals that are designed to improve the performance and health of livestock. Some of the company's key products include Amprolium, an antibiotic for the treatment of coccidiosis commonly found in poultry; Autogenous Vaccines, customized vaccines tailored to the specific needs of a farm for higher effectiveness; Salinomycin, an antibiotic for the prevention of coccidiosis in poultry; COOL-AID, a feed additive that lowers the body temperature of livestock to improve their well-being; and X-Zelit, a mineral feed additive that enhances phosphorus absorption in dairy cows and increases milk production. Phibro Animal Health Corp operates in over 60 countries, serving livestock owners and agricultural farms worldwide. The company is committed to developing innovative products that contribute to improving the quality of life for livestock and increasing the productivity and profitability of agricultural farms. Phibro Animal Health is one of the most popular companies on Eulerpool.com.

Phibro Animal Health SWOT Analysis

Strengths

Phibro Animal Health Corp has several notable strengths that contribute to its competitive advantage in the market:

  • Strong market presence and established reputation in the animal health industry.
  • Diverse portfolio of products and services catering to different animal species and healthcare needs.
  • Robust research and development capabilities, allowing for continuous innovation and product improvement.
  • Strong distribution network, facilitating wide market reach and effective supply chain management.
  • Well-trained and knowledgeable sales force, enabling effective customer engagement and relationship building.

Weaknesses

Despite its strengths, Phibro Animal Health Corp also faces certain weaknesses that may impede its growth and market performance:

  • Dependence on a limited number of key suppliers for raw materials, potentially leading to supply chain disruptions.
  • Relatively high production costs compared to some competitors, affecting price competitiveness.
  • Vulnerability to regulatory changes and evolving industry standards, which may require costly adaptations and compliance measures.
  • Limited geographic presence in certain regions, resulting in missed market opportunities.

Opportunities

Phibro Animal Health Corp can leverage the following opportunities to further expand its market position and profitability:

  • Growing global demand for animal protein, providing an increased market for animal health products.
  • Increasing awareness and focus on animal welfare, driving demand for high-quality healthcare products.
  • Emerging markets with untapped potential, presenting opportunities for market expansion and revenue growth.
  • Advancements in technology and digital solutions, allowing for enhanced product development, distribution, and customer engagement.

Threats

Phibro Animal Health Corp faces certain threats that could potentially hinder its performance and competitive position:

  • Intense competition from other established players and new entrants in the animal health market.
  • Fluctuating prices of key raw materials and ingredients, impacting production costs and overall profitability.
  • Regulatory constraints and potential restrictions on the use of certain chemicals or medications in animal healthcare.
  • Public scrutiny and concerns regarding the environmental impact and sustainability practices of the animal agriculture industry.

Phibro Animal Health Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Phibro Animal Health historical P/E ratio, EBIT multiple, and P/S ratio

Phibro Animal Health shares outstanding

The number of shares was Phibro Animal Health in 2023 — This indicates how many shares 40.5 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Phibro Animal Health earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Phibro Animal Health's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Phibro Animal Health’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Phibro Animal Health's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Phibro Animal Health dividend history and estimates

In 2023, Phibro Animal Health paid a dividend amounting to 0.48 USD. Dividend means that Phibro Animal Health distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Phibro Animal Health provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Phibro Animal Health’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Phibro Animal Health's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Phibro Animal Health Dividend History

DatePhibro Animal Health Dividend
2029e0.4 undefined
2028e0.4 undefined
2027e0.4 undefined
2026e0.4 undefined
2025e0.4 undefined
20240.36 undefined
20230.48 undefined
20220.48 undefined
20210.48 undefined
20200.48 undefined
20190.48 undefined
20180.42 undefined
20170.4 undefined
20160.4 undefined
20150.4 undefined
20140.2 undefined

Phibro Animal Health dividend payout ratio

In 2023, Phibro Animal Health had a payout ratio of 44.44%. The payout ratio indicates the percentage of the company's profits that Phibro Animal Health distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Phibro Animal Health represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Phibro Animal Health could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Phibro Animal Health's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Phibro Animal Health Payout Ratio History

DatePhibro Animal Health Payout ratio
2029e41.49 %
2028e41.46 %
2027e41.09 %
2026e41.93 %
2025e41.36 %
202439.98 %
202344.44 %
202239.67 %
202135.82 %
202057.83 %
201935.82 %
201826.25 %
201724.84 %
201619.32 %
201526.49 %
2014-200 %
201344.44 %
201244.44 %
201144.44 %
201044.44 %
200944.44 %
200844.44 %
200744.44 %
200644.44 %
200544.44 %
Unfortunately, there are currently no price targets and forecasts available for Phibro Animal Health.

Phibro Animal Health latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20240.34 0.41  (20.59 %)2024 Q4
3/31/20240.3 0.31  (4.8 %)2024 Q3
12/31/20230.29 0.33  (15.67 %)2024 Q2
9/30/20230.23 0.14  (-40.32 %)2024 Q1
6/30/20230.39 0.38  (-3.04 %)2023 Q4
3/31/20230.34 0.29  (-15.13 %)2023 Q3
12/31/20220.31 0.34  (10 %)2023 Q2
9/30/20220.27 0.21  (-22.39 %)2023 Q1
6/30/20220.39 0.26  (-33.38 %)2022 Q4
3/31/20220.36 0.33  (-8.44 %)2022 Q3
1
2
3
4
...
5

Eulerpool ESG Scorecard© for the Phibro Animal Health stock

Eulerpool World ESG Rating (EESG©)

47/ 100

🌱 Environment

49

👫 Social

76

🏛️ Governance

16

Environment

Scope 1 - Direct Emissions
27,297
Scope 2 - Indirect emissions from purchased energy
15,838
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
43,135
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
✅
Fur & Leather
—
Pesticides
✅
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
✅
Environmentally friendly packaging
❌
Hazardous substances
✅
Fuel consumption and efficiency
❌
Water consumption and efficiency
✅

Social

Percentage of female employees30
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Phibro Animal Health shareholders

%
Name
Stocks
Change
Date
8.13825 % BlackRock Institutional Trust Company, N.A.3,295,993212,57912/31/2023
5.25952 % Brandes Investment Partners, L.P.2,130,10789,72712/31/2023
4.91249 % Pzena Investment Management, LLC1,989,558-79,42812/31/2023
4.43441 % The Vanguard Group, Inc.1,795,937-445,59212/31/2023
2.33882 % State Street Global Advisors (US)947,22424,42812/31/2023
1.91876 % Dimensional Fund Advisors, L.P.777,09956,90412/31/2023
1.50520 % Millennium Management LLC609,605490,01212/31/2023
1.41877 % Renaissance Technologies LLC574,60047,90012/31/2023
1.33563 % Hotchkis and Wiley Capital Management, LLC540,930145,45012/31/2023
1.25539 % Acadian Asset Management LLC508,43183,45912/31/2023
1
2
3
4
5
...
10

Phibro Animal Health Executives and Management Board

Mr. Jack Bendheim76
Phibro Animal Health Chairman of the Board, President, Chief Executive Officer (since 1984)
Compensation 2.94 M
Mr. Larry Miller59
Phibro Animal Health Chief Operating Officer
Compensation 778,803
Mr. Rob Aukerman65
Phibro Animal Health President, North America Region
Compensation 619,272
Mr. Daniel Bendheim51
Phibro Animal Health Executive Vice President - Corporate Strategy, Director (since 2013)
Compensation 554,690
Mr. Richard Johnson74
Phibro Animal Health Interim Chief Financial Officer
Compensation 511,830
1
2
3

Most common questions regarding Phibro Animal Health

What values and corporate philosophy does Phibro Animal Health represent?

Phibro Animal Health Corp represents a strong commitment to animal health and welfare. They prioritize innovation, research, and development to provide solutions that enhance animal productivity and improve the quality of their lives. With a customer-centric approach, Phibro strives to understand and meet the unique needs of their clients. Their corporate philosophy revolves around driving sustainable growth, fostering meaningful partnerships, and delivering value to stakeholders. By combining expertise, cutting-edge technologies, and a dedication to animal care, Phibro Animal Health Corp establishes itself as a trusted leader in the industry, dedicated to improving animal health worldwide.

In which countries and regions is Phibro Animal Health primarily present?

Phibro Animal Health Corp is primarily present in various countries and regions. This global company has a wide reach, with its presence prominently seen in North America, Latin America, Europe, and Asia-Pacific. With its headquarters based in the United States, Phibro Animal Health Corp operates across more than 75 countries worldwide. The company's strong international presence allows it to offer its comprehensive range of animal health products and solutions to various markets across the globe.

What significant milestones has the company Phibro Animal Health achieved?

Phibro Animal Health Corp has achieved significant milestones since its inception. The company has expanded its global presence, becoming a leading provider of animal health solutions. Phibro has demonstrated consistent growth through strategic acquisitions and partnerships, enhancing its product portfolio and market reach. Additionally, the company has achieved several regulatory approvals for innovative products, strengthening its competitive edge. Phibro Animal Health Corp has also focused on sustainable practices, ensuring the production of safe and quality animal health products. These milestones reflect the company's commitment to advancing animal care and delivering value to its customers worldwide.

What is the history and background of the company Phibro Animal Health?

Phibro Animal Health Corp is a reputable company with a rich history and background. Originally known as a division of Pharmacia & Upjohn, it became an independent company in 2003. With a mission to provide innovative solutions for animal health and nutrition, Phibro Animal Health Corp has been a market leader for over 40 years. They offer a wide range of products and services to enhance animal productivity and improve the health and well-being of livestock. With a commitment to research and development, Phibro Animal Health Corp continues to drive advancements in the animal health industry, making them a trusted name in the market.

Who are the main competitors of Phibro Animal Health in the market?

Some of the main competitors of Phibro Animal Health Corp in the market include Zoetis Inc., Merck Animal Health, Elanco Animal Health, and Boehringer Ingelheim.

In which industries is Phibro Animal Health primarily active?

Phibro Animal Health Corp is primarily active in the animal health industry.

What is the business model of Phibro Animal Health?

Phibro Animal Health Corp operates as a diversified global animal health and mineral nutrition company. Their business model focuses on developing, manufacturing, and marketing a wide range of animal health pharmaceuticals and vaccines to improve animal productivity and promote public health. Additionally, the company offers various mineral nutrition products, including specialty ingredients used in animal feed. With a vast portfolio of products and a commitment to innovation, Phibro Animal Health Corp aims to enhance the health and performance of animals worldwide.

What is the P/E ratio of Phibro Animal Health 2024?

The Phibro Animal Health P/E ratio is 370.34.

What is the P/S ratio of Phibro Animal Health 2024?

The Phibro Animal Health P/S ratio is 0.88.

What is the AlleAktien quality score of Phibro Animal Health?

The AlleAktien quality score for Phibro Animal Health is 3/10.

What is the revenue of Phibro Animal Health 2024?

The Phibro Animal Health revenue is 1.02 B USD.

How high is the profit of Phibro Animal Health 2024?

The Phibro Animal Health profit is 2.42 M USD.

What is the business model of Phibro Animal Health

Phibro Animal Health Corporation is a global leader in providing products and services to the animal health and nutrition industry. The company's business model is based on providing innovative, high-quality products and services that improve the health and performance of livestock while increasing profitability for animal owners and feed producers. The company offers a wide range of products and services in various sectors of the animal health and nutrition industry. These sectors include animal pharmaceuticals, vaccines, feed additives, and technical services. The animal pharmaceutical sector includes a wide range of antibiotics, antifungals, anti-inflammatories, and other medications for the treatment of pigs, poultry, cattle, and other livestock. The company has a strong pipeline of innovative animal pharmaceuticals that contribute to improving animal health and performance and help animal owners increase their profitability. Phibro Animal Health also offers an extensive range of veterinary vaccines used for the prevention of infectious diseases in animals. The vaccines are both inactivated and live, providing high protection against a variety of diseases. In addition to animal pharmaceuticals and vaccines, the company also offers feed additives that contribute to improving feed efficiency, digestion, and animal performance. Feed additives include probiotics, premixes, enzymes, and other additives. To provide comprehensive service to its customers, Phibro Animal Health also offers technical services such as training, testing, and custom solutions. The company works closely with its customers to understand their needs and provide specific solutions tailored to their requirements. Phibro Animal Health also has a strong presence in the global market, serving customers in over 65 countries. The company has production facilities on four continents and leverages its global presence to offer a wide range of products and services, providing its customers with a comprehensive service offering. Overall, the business model of Phibro Animal Health Corporation is based on providing innovative, high-quality products and services that improve the health and performance of livestock while increasing profitability for animal owners and feed producers. The company has a strong focus on research and development and works closely with its customers to provide specific solutions tailored to their requirements. With its strong presence in the global market, Phibro Animal Health is able to serve customers worldwide and achieve strong profitability in both the short and long term.

What is the Phibro Animal Health dividend?

Phibro Animal Health pays a dividend of 0.48 USD distributed over payouts per year.

How often does Phibro Animal Health pay dividends?

The dividend cannot currently be calculated for Phibro Animal Health or the company does not pay out a dividend.

What is the Phibro Animal Health ISIN?

The ISIN of Phibro Animal Health is US71742Q1067.

What is the Phibro Animal Health WKN?

The WKN of Phibro Animal Health is A1WZ6P.

What is the Phibro Animal Health ticker?

The ticker of Phibro Animal Health is PAHC.

How much dividend does Phibro Animal Health pay?

Over the past 12 months, Phibro Animal Health paid a dividend of 0.36 USD . This corresponds to a dividend yield of about 1.63 %. For the coming 12 months, Phibro Animal Health is expected to pay a dividend of 0.4 USD.

What is the dividend yield of Phibro Animal Health?

The current dividend yield of Phibro Animal Health is 1.63 %.

When does Phibro Animal Health pay dividends?

Phibro Animal Health pays a quarterly dividend. This is distributed in the months of December, April, July, October.

How secure is the dividend of Phibro Animal Health?

Phibro Animal Health paid dividends every year for the past 0 years.

What is the dividend of Phibro Animal Health?

For the upcoming 12 months, dividends amounting to 0.4 USD are expected. This corresponds to a dividend yield of 1.81 %.

In which sector is Phibro Animal Health located?

Phibro Animal Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Phibro Animal Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Phibro Animal Health from 9/25/2024 amounting to 0.12 USD, you needed to have the stock in your portfolio before the ex-date on 9/4/2024.

When did Phibro Animal Health pay the last dividend?

The last dividend was paid out on 9/25/2024.

What was the dividend of Phibro Animal Health in the year 2023?

In the year 2023, Phibro Animal Health distributed 0.48 USD as dividends.

In which currency does Phibro Animal Health pay out the dividend?

The dividends of Phibro Animal Health are distributed in USD.

All fundamentals about Phibro Animal Health

Our stock analysis for Phibro Animal Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Phibro Animal Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.